Advanced Laboratory Methods for Detecting Yellow Fever Pathogen
Yellow fever is an acute infectious disease of viral nature, the causative agent of which is vector-borne –is transmitted through the bites of infected mosquitoes. Massive epidemics caused by the yellow fever virus are observed in the countries of Africa, South and Central America annually. Imported...
| Published in: | Проблемы особо опасных инфекций |
|---|---|
| Main Authors: | E. I. Krivosheina, M. Yu. Kartashov, E. V. Naidenova |
| Format: | Article |
| Language: | Russian |
| Published: |
Federal Government Health Institution, Russian Research Anti-Plague Institute “Microbe”
2021-07-01
|
| Subjects: | |
| Online Access: | https://journal.microbe.ru/jour/article/view/1469 |
Similar Items
Development and validation of RT-LAMP for detecting yellow fever virus in non-human primates samples from Brazil
by: Sabrina F. Cardoso, et al.
Published: (2024-09-01)
by: Sabrina F. Cardoso, et al.
Published: (2024-09-01)
The thermal stability of yellow fever vaccines
by: Ricardo Ishak, et al.
Published: (1990-09-01)
by: Ricardo Ishak, et al.
Published: (1990-09-01)
Development of a method for detection of specific antibodies to E protein of yellow fever virus (Flaviviridae: Flavivirus) by enzyme immunoassay
by: Ekaterina I. Krivosheina, et al.
Published: (2022-11-01)
by: Ekaterina I. Krivosheina, et al.
Published: (2022-11-01)
Sustained circulation of yellow fever virus in Cameroon: an analysis of laboratory surveillance data, 2010–2020
by: Fredy Brice Simo Nemg, et al.
Published: (2022-04-01)
by: Fredy Brice Simo Nemg, et al.
Published: (2022-04-01)
Development of inactivated cultural yellow fever vaccine
by: A. P. Ivanov, et al.
Published: (2020-09-01)
by: A. P. Ivanov, et al.
Published: (2020-09-01)
Yellow Fever Virus (YFV) Detection in Different Species of Culicids Collected During an Outbreak in Southeastern Brazil, 2016–2019
by: Giovana Santos Caleiro, et al.
Published: (2025-04-01)
by: Giovana Santos Caleiro, et al.
Published: (2025-04-01)
What Constitutes Protective Immunity Following Yellow Fever Vaccination?
by: Jolynne Mokaya, et al.
Published: (2021-06-01)
by: Jolynne Mokaya, et al.
Published: (2021-06-01)
Risk factors associated with in-hospital mortality during yellow fever outbreak in Brazil
by: Max McClure, et al.
Published: (2025-01-01)
by: Max McClure, et al.
Published: (2025-01-01)
Wild-Type Yellow Fever Virus RNA in Cerebrospinal Fluid of Child
by: Paula E.S. Marinho, et al.
Published: (2019-08-01)
by: Paula E.S. Marinho, et al.
Published: (2019-08-01)
Wild-type Yellow fever virus in cerebrospinal fluid from fatal cases in Brazil, 2018
by: Izabela Mauricio de Rezende, et al.
Published: (2022-09-01)
by: Izabela Mauricio de Rezende, et al.
Published: (2022-09-01)
Experimental Yellow Fever in Squirrel Monkey: Characterization of Liver In Situ Immune Response
by: Milene S. Ferreira, et al.
Published: (2023-02-01)
by: Milene S. Ferreira, et al.
Published: (2023-02-01)
Ensuring the Safety of Yellow Fever Vaccination in Travelers—The Experience at a Large U.S. Academic Medical Center in Colorado
by: Mehdi Bandali, et al.
Published: (2020-07-01)
by: Mehdi Bandali, et al.
Published: (2020-07-01)
Use of MAC-ELISA for evaluation of yellow fever vaccination Uso do MAC-ELISA para avaliação de vacinados contra febre amarela
by: Rita M. Ribeiro Nogueira, et al.
Published: (1992-10-01)
by: Rita M. Ribeiro Nogueira, et al.
Published: (1992-10-01)
Yellow Fever Virus Vaccine Reduces T Cell Receptor Signaling and the Levels of Phosphatase PTPRE In Vivo
by: Jinhua Xiang, et al.
Published: (2020-06-01)
by: Jinhua Xiang, et al.
Published: (2020-06-01)
YELLOW ALERT: Persistent Yellow Fever Virus Circulation among Non-Human Primates in Urban Areas of Minas Gerais State, Brazil (2021–2023)
by: Gabriela F. Garcia-Oliveira, et al.
Published: (2023-12-01)
by: Gabriela F. Garcia-Oliveira, et al.
Published: (2023-12-01)
Safety and Immunogenicity of the Attenuated Yellow Fever Vaccine in Several Neotropical Primate Species
by: Nayara Ferreira de Paula, et al.
Published: (2025-04-01)
by: Nayara Ferreira de Paula, et al.
Published: (2025-04-01)
Travel pattern and profile of clients using online registration system and mobile accessibility for vaccination in a newly established yellow fever vaccination clinic at AIIMS Patna, India
by: Dhananjay Kumar, et al.
Published: (2017-01-01)
by: Dhananjay Kumar, et al.
Published: (2017-01-01)
Yellow fever
by: Prata Aluízio
Published: (2000-01-01)
by: Prata Aluízio
Published: (2000-01-01)
The Usefulness of a Duplex RT-qPCR during the Recent Yellow Fever Brazilian Epidemic: Surveillance of Vaccine Adverse Events, Epizootics and Vectors
by: Alice L. N. Queiroz, et al.
Published: (2021-06-01)
by: Alice L. N. Queiroz, et al.
Published: (2021-06-01)
Viscerotropic disease and acute uveitis following yellow fever vaccination: a case report
by: Lev Volkov, et al.
Published: (2020-02-01)
by: Lev Volkov, et al.
Published: (2020-02-01)
The COVID-19 Impact on the Trends in Yellow Fever and Lassa Fever Infections in Nigeria
by: Nnennaya U. Opara, et al.
Published: (2022-11-01)
by: Nnennaya U. Opara, et al.
Published: (2022-11-01)
Molecular Characterization of Circulating Yellow Fever Viruses from Outbreak in Ghana, 2021–2022
by: Joseph Humphrey Kofi Bonney, et al.
Published: (2023-09-01)
by: Joseph Humphrey Kofi Bonney, et al.
Published: (2023-09-01)
Yellow fever vaccination: should India have more centres?
by: Vikas Bhatia, et al.
Published: (2015-01-01)
by: Vikas Bhatia, et al.
Published: (2015-01-01)
To vaccinate or let it be – current recommendations and the reality about yellow fever vaccination
by: Silja Bühler, et al.
Published: (2014-12-01)
by: Silja Bühler, et al.
Published: (2014-12-01)
Uncovering Hidden Transmission: Active Surveillance Reveals Cryptic Circulation of Yellow Fever Virus in Urban Marmosets in Belo Horizonte, Brazil, 2024
by: Matheus Soares Arruda, et al.
Published: (2025-09-01)
by: Matheus Soares Arruda, et al.
Published: (2025-09-01)
A Yellow Fever Virus 17D Infection and Disease Mouse Model Used to Evaluate a Chimeric Binjari-Yellow Fever Virus Vaccine
by: Kexin Yan, et al.
Published: (2020-07-01)
by: Kexin Yan, et al.
Published: (2020-07-01)
Vaccination against yellow fever in rheumatic diseases
by: B. S. Belov, et al.
Published: (2019-10-01)
by: B. S. Belov, et al.
Published: (2019-10-01)
Vector Competence of <i>Aedes albopictus</i> for Yellow Fever Virus: Risk of Reemergence of Urban Yellow Fever in Brazil
by: Rossela Damasceno-Caldeira, et al.
Published: (2023-04-01)
by: Rossela Damasceno-Caldeira, et al.
Published: (2023-04-01)
A Single Dose of Yellow Fever Vaccine Provides Long-Term Immunity in Japanese Travelers
by: Shinji Fukushima, et al.
Published: (2025-06-01)
by: Shinji Fukushima, et al.
Published: (2025-06-01)
Late or Lack of Vaccination Linked to Importation of Yellow Fever from Angola to China
by: Rui Song, et al.
Published: (2018-07-01)
by: Rui Song, et al.
Published: (2018-07-01)
Yellow Fever in a Worker Returning to China from Angola, March 2016
by: Yun Ling, et al.
Published: (2016-07-01)
by: Yun Ling, et al.
Published: (2016-07-01)
Low frequency of side effects following an incidental 25 times concentrated dose of yellow fever vaccine
by: Ana Rabello, et al.
Published: (2002-04-01)
by: Ana Rabello, et al.
Published: (2002-04-01)
Yellow Fever: Roles of Animal Models and Arthropod Vector Studies in Understanding Epidemic Emergence
by: Divya P. Shinde, et al.
Published: (2022-08-01)
by: Divya P. Shinde, et al.
Published: (2022-08-01)
Severe Multiorgan Failure Following Yellow Fever Vaccination
by: Cristina Domingo, et al.
Published: (2020-05-01)
by: Cristina Domingo, et al.
Published: (2020-05-01)
Risk of arboviral transmission and insecticide resistance status of Aedes mosquitoes during a yellow fever outbreak in Ghana
by: Margaret Owusu-Akyaw, et al.
Published: (2024-07-01)
by: Margaret Owusu-Akyaw, et al.
Published: (2024-07-01)
Serological evidence for potential yellow fever virus infection in non-human primates, southeastern Mexico
by: Mónica Salas-Rojas, et al.
Published: (2023-10-01)
by: Mónica Salas-Rojas, et al.
Published: (2023-10-01)
Oral Susceptibility to Yellow Fever Virus of Aedes aegypti from Brazil
by: Ricardo Lourenço-de-Oliveira, et al.
Published: (2002-04-01)
by: Ricardo Lourenço-de-Oliveira, et al.
Published: (2002-04-01)
Yellow Fever Outbreak in Brazil: A crucial time for epidemiologic surveillance
by: Priscila Carminati Siqueira, et al.
Published: (2019-04-01)
by: Priscila Carminati Siqueira, et al.
Published: (2019-04-01)
Yellow Fever in Nigeria: A Review of Past, Current, and Future Strides
by: Anyebe B. Onoja, et al.
Published: (2022-10-01)
by: Anyebe B. Onoja, et al.
Published: (2022-10-01)
Current Trends of Yellow Fever in Nigeria: Challenges and Prospects
by: Abdulkadir B., et al.
Published: (2019-12-01)
by: Abdulkadir B., et al.
Published: (2019-12-01)
Similar Items
-
Development and validation of RT-LAMP for detecting yellow fever virus in non-human primates samples from Brazil
by: Sabrina F. Cardoso, et al.
Published: (2024-09-01) -
The thermal stability of yellow fever vaccines
by: Ricardo Ishak, et al.
Published: (1990-09-01) -
Development of a method for detection of specific antibodies to E protein of yellow fever virus (Flaviviridae: Flavivirus) by enzyme immunoassay
by: Ekaterina I. Krivosheina, et al.
Published: (2022-11-01) -
Sustained circulation of yellow fever virus in Cameroon: an analysis of laboratory surveillance data, 2010–2020
by: Fredy Brice Simo Nemg, et al.
Published: (2022-04-01) -
Development of inactivated cultural yellow fever vaccine
by: A. P. Ivanov, et al.
Published: (2020-09-01)
